{"id":"control-vaccine-with-the-adjuvant-system","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The adjuvant system in this vaccine helps to enhance the immune response by activating immune cells and increasing the production of antibodies. This leads to the development of immune memory, which can provide long-term protection against future infections.","oneSentence":"This vaccine works by stimulating the body's immune system to produce a specific response against a target antigen.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:28:40.639Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19"}]},"trialDetails":[{"nctId":"NCT06062238","phase":"PHASE3","title":"Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gates Medical Research Institute","startDate":"2024-03-05","conditions":"Tuberculosis","enrollment":20080},{"nctId":"NCT04985760","phase":"PHASE1","title":"Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy","status":"COMPLETED","sponsor":"Madhu Chhanda Choudhary","startDate":"2021-09-30","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT05561673","phase":"PHASE1","title":"A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-10-04","conditions":"Hepatitis B","enrollment":122},{"nctId":"NCT05879419","phase":"PHASE4","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2023-05-23","conditions":"Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis","enrollment":2005},{"nctId":"NCT04556981","phase":"PHASE2","title":"Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV","status":"COMPLETED","sponsor":"Gates Medical Research Institute","startDate":"2020-11-17","conditions":"Human Immunodeficiency Virus","enrollment":402},{"nctId":"NCT06851832","phase":"PHASE1, PHASE2","title":"Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older","status":"RECRUITING","sponsor":"Ab&B Bio-tech Co., Ltd.JS","startDate":"2025-02-16","conditions":"Herpes Zoster, Herpes Zoster Vaccine","enrollment":960},{"nctId":"NCT05303584","phase":"PHASE4","title":"Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2022-04-23","conditions":"COVID-19","enrollment":362},{"nctId":"NCT03181789","phase":"PHASE1","title":"Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-10-18","conditions":"HIV Infections","enrollment":56},{"nctId":"NCT04523246","phase":"EARLY_PHASE1","title":"Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2020-09-01","conditions":"Herpes Zoster, Allergy and Immunology, Corona Virus Infection","enrollment":217},{"nctId":"NCT04789577","phase":"PHASE2","title":"A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-03-16","conditions":"Influenza, Human","enrollment":833},{"nctId":"NCT02699099","phase":"PHASE3","title":"Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-10","conditions":"Malaria, Malaria Vaccines","enrollment":699},{"nctId":"NCT01097096","phase":"PHASE2","title":"Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-03","conditions":"Alzheimer's Disease","enrollment":177},{"nctId":"NCT01573312","phase":"PHASE1","title":"H5N1 Vaccination With and Without AS03: Systems Biology Analysis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-05-24","conditions":"Influenza","enrollment":20},{"nctId":"NCT01418235","phase":"PHASE1","title":"Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2011-12-19","conditions":"HIV Seronegativity, HIV Preventive Vaccine","enrollment":184},{"nctId":"NCT00397943","phase":"PHASE2","title":"Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11-15","conditions":"Tuberculosis","enrollment":110},{"nctId":"NCT01157897","phase":"PHASE1, PHASE2","title":"Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2010-07","conditions":"Malaria, Plasmodium Vivax","enrollment":41},{"nctId":"NCT00707967","phase":"PHASE2","title":"Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-06-30","conditions":"Tuberculosis","enrollment":37},{"nctId":"NCT02174978","phase":"PHASE1","title":"Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2014-08","conditions":"Malaria","enrollment":39},{"nctId":"NCT01556945","phase":"PHASE1, PHASE2","title":"Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2001-04","conditions":"Malaria, Falciparum","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":247,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Control vaccine with the adjuvant system.","genericName":"Control vaccine with the adjuvant system.","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"This vaccine works by stimulating the body's immune system to produce a specific response against a target antigen. Used for Prevention of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}